Last modified: December 1, 2020
I. PURPOSE
TwinStrand Biosciences, Inc. (TSB) strives to create a research climate that promotes objectivity in research. The purpose of this policy is to establish standards to ensure that the design, conduct and reporting of Public Health Service (PHS)-funded research (including research funded by the National Institutes of Health (NIH) and other governmental and governmentally-funded organizations) is free from bias resulting from financial conflict of interest (FCOI) in accordance with 42 CFR Part 50 Subpart F.
II. POLICY
TwinStrand Biosciences strives to create a research climate that promotes objectivity in research by establishing standards such that the design, conduct and reporting of PHS-funded research is free from bias resulting from FCOI.
This policy is applicable to any TSB employee who is planning to or is participating in research activity that is either partially or wholly supported by PHS funds. It will be understood that any reference to “employee” herein also refers to consultants and other non-employees performing research under contract with TSB. Each employee engaged in PHS-funded research must:
Disclosure of SFI is essential for TwinStrand to determine if a FCOI exists, and in cases of FCOI determine how it will be managed and reported in full compliance with government regulation. Non-disclosure of SFI or non-compliance with a FCOI management plan may subject the employee to employment discipline including, without limitation, suspension or termination of employment.
III. DEFINITIONS
For Research Use Only. Not for use in diagnostic procedures.
©2024 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners. Legal Notices
Stay up to date
Danielle LeBlanc is a Biologist at Health Canada under the supervision of Dr. Francesco Marchetti. Danielle completed her undergraduate and Masters work at Carleton University in Ottawa. Danielle is currently focusing on the implementation of Duplex Sequencing for in vivo mutagenesis assessment at Health Canada.
In her spare time, she loves to cross-country ski, bake cupcakes and craft cocktails.
Dr. Francesco Marchetti is a Senior Research Scientist at Health Canada and Adjunct Research Professor at Carleton University. He chairs the Germ Cell workgroup of the Health and Environmental Science Institute’s Genetic Toxicology Technical Committee and is a member of the Organisation for the Economic Co-Operation and Development Expert Group on Genotoxicity Testing. Dr. Marchetti has authored over 125 peer-reviewed publications.
He was Editor-In-Chief of Environmental and Molecular Mutagenesis (EMM) during 2012-2016 and serves on the editorial boards of EMM and Mutagenesis. Dr. Marchetti is the current President of the Environmental Mutagenesis and Genomic Society.